Literature DB >> 27149905

Waist circumference is correlated with poorer cognition in elderly type 2 diabetes women.

Rebecca K West1, Ramit Ravona-Springer2, Anthony Heymann3, James Schmeidler4, Derek Leroith5, Keren Koifman2, Ryan C N D'Arcy6, Xiaowei Song6, Elizabeth Guerrero-Berroa7, Rachel Preiss2, Hadas Hoffman2, Mary Sano7, Jeremy M Silverman7, Michal Schnaider-Beeri8.   

Abstract

INTRODUCTION: Waist circumference is associated with type 2 diabetes (T2D) and cognition, yet the relationship between waist circumference and cognition in individuals with T2D is not well understood.
METHODS: We studied the relationship of waist circumference with five cognitive outcomes (executive functioning, language/semantic categorization, attention/working memory, episodic memory, and an overall cognition measure) in 845 cognitively normal elderly with type 2 diabetes (T2D).
RESULTS: In women, waist circumference was correlated with significantly lower language and/or semantic categorization performance (P < .0001), executive functioning (P = .026), and overall cognition (P = .003) after controlling for age, education, BMI, and cardiovascular, diabetes-related, APOE ε4, and inflammatory potential confounders. Attention/working memory (P = .532) and episodic memory (P = .144) were not associated with waist circumference. These correlations were not found in men. DISCUSSION: These results suggest that central adiposity in elderly women with T2D may increase their risk for dementia.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Cognitive performance; Dementia; Risk factors; Type 2 diabetes mellitus; Waist circumference

Mesh:

Year:  2016        PMID: 27149905      PMCID: PMC5753411          DOI: 10.1016/j.jalz.2016.03.017

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  20 in total

1.  Assessing adiposity: a scientific statement from the American Heart Association.

Authors:  Marc-Andre Cornier; Jean-Pierre Després; Nichola Davis; Daurice A Grossniklaus; Samuel Klein; Benoit Lamarche; Francisco Lopez-Jimenez; Goutham Rao; Marie-Pierre St-Onge; Amytis Towfighi; Paul Poirier
Journal:  Circulation       Date:  2011-09-26       Impact factor: 29.690

2.  The Israel Diabetes and Cognitive Decline (IDCD) study: Design and baseline characteristics.

Authors:  Michal Schnaider Beeri; Ramit Ravona-Springer; Erin Moshier; James Schmeidler; James Godbold; Tomas Karpati; Derek Leroith; Keren Koifman; Efrat Kravitz; Rachel Price; Hadas Hoffman; Jeremy M Silverman; Anthony Heymann
Journal:  Alzheimers Dement       Date:  2014-08-20       Impact factor: 21.566

3.  Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis.

Authors:  M A Beydoun; H A Beydoun; Y Wang
Journal:  Obes Rev       Date:  2008-03-06       Impact factor: 9.213

4.  Long-term systemic inflammation and cognitive impairment in a population-based cohort.

Authors:  Margarete A Wichmann; Karen J Cruickshanks; Cynthia M Carlsson; Rick Chappell; Mary E Fischer; Barbara E K Klein; Ronald Klein; Michael Y Tsai; Carla R Schubert
Journal:  J Am Geriatr Soc       Date:  2014-08-14       Impact factor: 5.562

5.  Risk and protective factors for cognitive impairment in persons aged 85 years and older.

Authors:  Rosebud O Roberts; Ruth H Cha; Michelle M Mielke; Yonas E Geda; Bradley F Boeve; Mary M Machulda; David S Knopman; Ronald C Petersen
Journal:  Neurology       Date:  2015-04-08       Impact factor: 9.910

6.  Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology.

Authors:  L Franzini; D Ardigò; F Cavalot; R Miccoli; A A Rivellese; M Trovati; I Zavaroni; O Vaccaro
Journal:  Nutr Metab Cardiovasc Dis       Date:  2012-03-06       Impact factor: 4.222

Review 7.  Estrogen, hormonal replacement therapy and cardiovascular disease.

Authors:  Xiao-Ping Yang; Jane F Reckelhoff
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-03       Impact factor: 2.894

8.  The diabetes risk score: a practical tool to predict type 2 diabetes risk.

Authors:  Jaana Lindström; Jaakko Tuomilehto
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

9.  The metabolic syndrome and cognitive decline in the Atherosclerosis Risk in Communities study (ARIC).

Authors:  Jennifer L Dearborn; David Knopman; A Richey Sharrett; Andrea L C Schneider; Clifford R Jack; Laura H Coker; Alvaro Alonso; Elizabeth Selvin; Thomas H Mosley; Lynne E Wagenknecht; Beverly G Windham; Rebecca F Gottesman
Journal:  Dement Geriatr Cogn Disord       Date:  2014-08-20       Impact factor: 2.959

10.  The association of duration of type 2 diabetes with cognitive performance is modulated by long-term glycemic control.

Authors:  Rebecca K West; Ramit Ravona-Springer; James Schmeidler; Derek Leroith; Keren Koifman; Elizabeth Guerrero-Berroa; Rachel Preiss; Hadas Hoffman; Jeremy M Silverman; Anthony Heymann; Michal Schnaider-Beeri
Journal:  Am J Geriatr Psychiatry       Date:  2014-01-23       Impact factor: 4.105

View more
  4 in total

1.  The Association Between Diet and Cardio-Metabolic Risk on Cognitive Performance: A Cross-Sectional Study of Middle-Aged Australian Adults.

Authors:  Sarah Gauci; Lauren M Young; Lizanne Arnoldy; Andrew Scholey; David J White; Annie-Claude Lassemillante; Denny Meyer; Andrew Pipingas
Journal:  Front Nutr       Date:  2022-04-28

2.  Subjective age and risk of incident dementia: Evidence from the National Health and Aging Trends survey.

Authors:  Yannick Stephan; Angelina R Sutin; Martina Luchetti; Antonio Terracciano
Journal:  J Psychiatr Res       Date:  2018-02-10       Impact factor: 4.791

3.  Stability in BMI over time is associated with a better cognitive trajectory in older adults.

Authors:  Michal Schnaider Beeri; Amir Tirosh; Hung-Mo Lin; Sapir Golan; Ethel Boccara; Mary Sano; Carolyn W Zhu
Journal:  Alzheimers Dement       Date:  2022-01-20       Impact factor: 16.655

4.  The factors contributing to cognitive dysfunction in type 2 diabetic patients.

Authors:  San-Shan Xia; Wen-Lin Xia; Jiao-Jiao Huang; Hua-Jie Zou; Jing Tao; Yan Yang
Journal:  Ann Transl Med       Date:  2020-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.